Suppression of tumor growth and pulmonary metastasis in murine osteosarcoma using gene therapy

Oncology Reports

Volumn 9, Issue 2, 2002, Pages 337-340

  Seto, Masashi ^a   Yamazaki, Takashi ^a   Sonoda, Jun ^a   Matsumine, Akihiko ^a   Shinto, Yoshitaka ^b   Uchida, Atsumasa ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Department of Radiology   (Japan)

Author keywords

Bystander effect; Gene therapy; Osteosarcoma; Retrovirus vectors; Suicide gene

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE;

ADENOVIRUS; ANIMAL; ARTICLE; BONE TUMOR; CANCER TRANSPLANTATION; CBA MOUSE; CELL CULTURE; ENZYMOLOGY; GENE THERAPY; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; GENETICS; HERPES SIMPLEX VIRUS; HUMAN; LUNG TUMOR; MALE; METASTASIS; METHODOLOGY; MOUSE; OSTEOSARCOMA; PATHOLOGY; SURVIVAL RATE;

ADENOVIRIDAE; ANIMALS; BONE NEOPLASMS; GANCICLOVIR; GENE THERAPY; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED CBA; NEOPLASM TRANSPLANTATION; OSTEOSARCOMA; SIMPLEXVIRUS; SURVIVAL RATE; THYMIDINE KINASE; TRANSDUCTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0036517736     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.9.2.337     Document Type: Article

References (10)

1. Marcove RC and Lewis MM: Prolonged survival in osteogenic sarcoma with multiple pulmonary metastases. J Bone Joint Surg Am 55: 1516-1520, 1973.
2. Marcove RC, Martin N, Rosen G, et al: The treatment of pulmonary metastasis in osteogenic sarcoma. Clin Orthop 111: 65-70, 1975.
3. Seto M, Wakabayashi H, Yamazaki T, Sonoda J, Shinto Y and Uchida A: Gene therapy of chondrosarcoma using retrovirus vectors encoding the herpes simplex virus thymidine kinase gene. IntJ Oncol 14: 1137-1141, 1999.
4. Elshami AA, Saaverdra A, Zhang H, Kucharczuk JC, Spray DC, Fishman Gl, Amin KM, Kaiser LR and Albelda SM: Gap junctions play a role in the 'bystander effect' of the herpes simplex virus thymidine kinase/ganciclovir system in vitro. Gene Ther 3: 85-92, 1996.
5. Asai T, Ueda T, Itoh K, Yoshida K, Aoki Y, Mori S and Yoshikawa H: Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to lung. Int J Cancer 76: 418-422, 1998.
6. Klatzmann D: Gene therapy for metastatic malignant melanoma: evaluation of tolerance to intratumoral injection of cells producing recombinant retroviruses carrying the herpes simplex virus type 1 thymidine kinase gene, to be followed by ganciclovir administration. Hum Gene Ther 7: 255-267, 1996.
7. Hasegawa Y, Emi N, Shimokata K, Abe A, Kawabe T, Hasegawa T, Kirioka T and Saito H: Gene transfer of herpes simplex virus type I thymidine kinase gene as a drug sensitivity gene into human lung cancer cell lines using retrovirus vectors. Am J Respir Cell Mol Biol 8: 655-661, 1993.
8. Esandi MC, van Someren GD, Vincent AJPE, van Bekkum DW, Valerio D, Bout A and Noteboom JL: Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding HSV-tk gene. Gene Ther 4: 280-287, 1997.
9. Paquin A, Jaalouk DE and Galipeau J: Retrovector encoding a green fluorescent protein-herpes simplex virus thymidine kinase fusion protein serves as a versatile suicide/reporter for cell and gene therapy applications. Hum Gene Ther 12: 13-23, 2001.
10. Cordier L, Gao GP, Hack AA, McNally EM, Wilson JM, Chirmule N and Sweeney HL: Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies. Hum Gene Ther 12: 205-215,2001.